10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
ABBOTT LABORATORIES | |||
Ticker: ABT Fiscal Year: 2018 | |||
Consolidated Statement of Cash Flows | |||
Period Ending Dec 31, 2018 10-K (Filed: Feb 22, 2019) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | |
| Cash Flow From (Used in) Operating Activities: | |||
| Net earnings | $ 2,368 | 477 | 1,400 |
| Adjustments to reconcile net earnings to net cash from operating activities - | |||
| Depreciation | 1,100 | 1,046 | 803 |
| Amortization of intangible assets | 2,178 | 1,975 | 550 |
| Share-based compensation | 477 | 406 | 310 |
| Impact of currency devaluation | 480 | ||
| Amortization of inventory step-up | 32 | 907 | |
| Investing and financing losses, net | 126 | 47 | 86 |
| Loss on extinguishment of debt | 167 | ||
| Amortization of bridge financing fees | 5 | 165 | |
| Gains on sale of businesses | (1,163) | (25) | |
| Mylan N.V. equity investment adjustment | 947 | ||
| Gain on sale of Mylan N.V. shares | (45) | ||
| Trade receivables | (190) | (207) | (177) |
| Inventories | (514) | 249 | (98) |
| Prepaid expenses and other assets | 23 | 109 | 113 |
| Trade accounts payable and other liabilities | 747 | 615 | (652) |
| Income taxes | (214) | 1,149 | (699) |
| Net Cash From Operating Activities | 6,300 | 5,570 | 3,203 |
| Cash Flow From (Used in) Investing Activities: | |||
| Acquisitions of property and equipment | (1,394) | (1,135) | (1,121) |
| Acquisitions of businesses and technologies, net of cash acquired | (17,183) | (80) | |
| Proceeds from business dispositions | 48 | 6,042 | 25 |
| Proceeds from the sale of Mylan N.V. shares | 2,704 | ||
| Purchases of investment securities | (131) | (210) | (2,823) |
| Proceeds from sales of investment securities | 73 | 129 | 3,709 |
| Other | 48 | 35 | 42 |
| Net Cash From (Used in) Investing Activities | (1,356) | (9,618) | (248) |
| Cash Flow From (Used in) Financing Activities: | |||
| Proceeds from issuance of (repayments of) short-term debt and other | (26) | (1,034) | (1,767) |
| Proceeds from issuance of long-term debt and debt with maturities over 3 months | 4,009 | 6,742 | 14,934 |
| Repayments of long-term debt and debt with maturities over 3 months | (12,433) | (8,650) | (12) |
| Payment of bridge financing fees | (170) | ||
| Purchase of Alere preferred stock | (710) | ||
| Acquisition and contingent consideration payments related to business acquisitions | (13) | (25) | |
| Purchases of common shares | (238) | (117) | (522) |
| Proceeds from stock options exercised | 271 | 350 | 248 |
| Dividends paid | (1,974) | (1,849) | (1,539) |
| Net Cash From (Used in) Financing Activities | (10,391) | (5,281) | 11,147 |
| Effect of exchange rate changes on cash and cash equivalents | (116) | 116 | (483) |
| Net Increase (Decrease) in Cash and Cash Equivalents | (5,563) | (9,213) | 13,619 |
| Cash and Cash Equivalents, Beginning of Year | 9,407 | 18,620 | 5,001 |
| Cash and Cash Equivalents, End of Period | 3,844 | 9,407 | 18,620 |
| Supplemental Cash Flow Information: | |||
| Income taxes paid | 740 | 570 | 620 |
| Interest paid | 845 | 917 | 181 |
| External Links | |
| ABBOTT LABORATORIES (ABT) Fiscal Year 2018 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |